Feedback / Questions
camidanlumab tesirine (ADCT-301) - Genmab, ADC Therapeutics
Zynlonta (loncastuximab tesirine) - Overland ADCT BioPharma, Mitsubishi Tanabe, SOBI
https://www.businesswire.com/news/home/20221102006135/en/ADC-Therapeutics-Announces-Abstracts-Accepted-for-Presentation-at-the-64th-ASH-Annual-Meeting
Nov 3, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next